Department of Biology, Oberlin College, Oberlin, OH, USA.
Department of Biology and Chemistry, Changwon National University, Changwon, Korea.
Exp Mol Med. 2020 Jun;52(6):887-895. doi: 10.1038/s12276-020-0450-9. Epub 2020 Jun 15.
Extracellular vesicles (EVs) present numerous biomedical ways of studying disease and pathology. They function as protective packaging for the delivery of controlled concentrations of miRNAs and effector molecules, including cytokines, chemokines, genetic material, and small signaling molecules. Previous studies of EVs have yielded valuable insights into pathways of intercellular communication that affect a variety of biological processes and disease responses. The roles of EVs, specifically microRNA-containing EVs (EV-miRNAs), in either mitigating or exacerbating pulmonary disease symptoms are numerous and show promise in helping us understand pulmonary disease pathology. Because of their well-documented involvement in pulmonary diseases, EVs show promise both as possible diagnostic biomarkers and as therapeutic agents. This review surveys the physiological functions of EVs in the respiratory system and outlines the pulmonary disease states in which EVs are involved in intercellular crosstalk. This review also discusses the potential clinical applications of EV-miRNAs in pulmonary diseases.
细胞外囊泡 (EVs) 为研究疾病和病理学提供了许多医学途径。它们作为受控浓度的 miRNAs 和效应分子(包括细胞因子、趋化因子、遗传物质和小信号分子)递呈的保护包装而发挥作用。EVs 的先前研究为影响多种生物过程和疾病反应的细胞间通讯途径提供了宝贵的见解。EVs(特别是含有 microRNA 的 EVs,即 EV-miRNAs)在减轻或加重肺病症状方面的作用很多,并有望帮助我们了解肺病病理学。由于它们在肺部疾病中已有充分记录的参与,EVs 作为潜在的诊断生物标志物和治疗剂都具有很大的应用潜力。本文综述了 EVs 在呼吸系统中的生理功能,并概述了 EVs 参与细胞间通讯的肺部疾病状态。本文还讨论了 EV-miRNAs 在肺部疾病中的潜在临床应用。